Outcomes in participants with ventilated nosocomial pneumonia and organ failure treated with ceftolozane/tazobactam versus meropenem: a subset analysis of the phase 3, randomized, controlled ASPECT-NP trial
CC BY
Lưu vào:
Tác giả chính: | , , |
---|---|
Định dạng: | Sách |
Ngôn ngữ: | English |
Nhà xuất bản: |
Springer
2023
|
Chủ đề: | |
Truy cập trực tuyến: | https://link.springer.com/article/10.1186/s13613-022-01084-8 https://dlib.phenikaa-uni.edu.vn/handle/PNK/7068 |
Từ khóa: |
Thêm từ khóa
Không có từ khóa, Hãy là người đầu tiên đánh dấu biểu ghi này!
|
id |
oai:localhost:PNK-7068 |
---|---|
record_format |
dspace |
spelling |
oai:localhost:PNK-70682023-03-22T09:08:46Z Outcomes in participants with ventilated nosocomial pneumonia and organ failure treated with ceftolozane/tazobactam versus meropenem: a subset analysis of the phase 3, randomized, controlled ASPECT-NP trial Ignacio, Martin-Loeches Andrew F., Shorr Richard G., Wunderink pivotal ASPECT-NP tria ventilator-associated bacterial pneumonia CC BY The pivotal ASPECT-NP trial showed ceftolozane/tazobactam was non-inferior to meropenem for the treatment of ventilated hospital-acquired/ventilator-associated bacterial pneumonia (vHABP/VABP). Here, we evaluated treatment outcomes by degree of respiratory or cardiovascular dysfunction. 2023-03-22T09:08:46Z 2023-03-22T09:08:46Z 2023 Book https://link.springer.com/article/10.1186/s13613-022-01084-8 https://dlib.phenikaa-uni.edu.vn/handle/PNK/7068 en application/pdf Springer |
institution |
Digital Phenikaa |
collection |
Digital Phenikaa |
language |
English |
topic |
pivotal ASPECT-NP tria ventilator-associated bacterial pneumonia |
spellingShingle |
pivotal ASPECT-NP tria ventilator-associated bacterial pneumonia Ignacio, Martin-Loeches Andrew F., Shorr Richard G., Wunderink Outcomes in participants with ventilated nosocomial pneumonia and organ failure treated with ceftolozane/tazobactam versus meropenem: a subset analysis of the phase 3, randomized, controlled ASPECT-NP trial |
description |
CC BY |
format |
Book |
author |
Ignacio, Martin-Loeches Andrew F., Shorr Richard G., Wunderink |
author_facet |
Ignacio, Martin-Loeches Andrew F., Shorr Richard G., Wunderink |
author_sort |
Ignacio, Martin-Loeches |
title |
Outcomes in participants with ventilated nosocomial pneumonia and organ failure treated with ceftolozane/tazobactam versus meropenem: a subset analysis of the phase 3, randomized, controlled ASPECT-NP trial |
title_short |
Outcomes in participants with ventilated nosocomial pneumonia and organ failure treated with ceftolozane/tazobactam versus meropenem: a subset analysis of the phase 3, randomized, controlled ASPECT-NP trial |
title_full |
Outcomes in participants with ventilated nosocomial pneumonia and organ failure treated with ceftolozane/tazobactam versus meropenem: a subset analysis of the phase 3, randomized, controlled ASPECT-NP trial |
title_fullStr |
Outcomes in participants with ventilated nosocomial pneumonia and organ failure treated with ceftolozane/tazobactam versus meropenem: a subset analysis of the phase 3, randomized, controlled ASPECT-NP trial |
title_full_unstemmed |
Outcomes in participants with ventilated nosocomial pneumonia and organ failure treated with ceftolozane/tazobactam versus meropenem: a subset analysis of the phase 3, randomized, controlled ASPECT-NP trial |
title_sort |
outcomes in participants with ventilated nosocomial pneumonia and organ failure treated with ceftolozane/tazobactam versus meropenem: a subset analysis of the phase 3, randomized, controlled aspect-np trial |
publisher |
Springer |
publishDate |
2023 |
url |
https://link.springer.com/article/10.1186/s13613-022-01084-8 https://dlib.phenikaa-uni.edu.vn/handle/PNK/7068 |
_version_ |
1761097142432169984 |
score |
8.891145 |